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Key Points
• Esophageal dysphagia is a commonly occurring symptom in clinical practice. Existing measures are either
lengthy and, thus, impractical for clinical practice or do not evaluate the presence of food impaction.
• The Brief Esophageal Dysphagia Questionnaire (BEDQ) is a reliable and valid rapid assessment tool for
esophageal dysphagia that also identifies food impaction symptoms.
• The BEDQ is easily implemented in clinical practice and may serve as a guide for further clinical evaluation of
patients presenting with esophageal dysphagia.
Abstract
Background Esophageal dysphagia is common in
gastroenterology practice and has multiple etiologies.
A complication for some patients with dysphagia is
food impaction. A valid and reliable questionnaire to
rapidly evaluate esophageal dysphagia and impaction
symptoms can aid the gastroenterologist in gathering
information to inform treatment approach and further
evaluation, including endoscopy. Methods 1638
patients participated over two study phases. 744
participants completed the Brief Esophageal Dyspha-
gia Questionnaire (BEDQ) for phase 1; 869 completed
the BEDQ, Visceral Sensitivity Index, Gastroe-
sophageal Reflux Disease Questionnaire, and Hospital
Anxiety and Depression Scale for phase 2. Demo-
graphic and clinical data were obtained via the
electronic medical record. The BEDQ was evaluated
for internal consistency, split-half reliability, ceiling
and floor effects, and construct validity. Key Results
The BEDQ demonstrated excellent internal consis-
tency, reliability, and construct validity. The
symptom frequency and severity scales scored above
the standard acceptable cutoffs for reliability while
the impaction subscale yielded poor internal consis-
tency and split-half reliability; thus the impaction
items were deemed qualifiers only and removed from
the total score. No significant ceiling or floor effects
were found with the exception of 1 item, and
inter-item correlations fell within accepted ranges.
Construct validity was supported by moderate yet
significant correlations with other measures. The
predictive ability of the BEDQ was small but signifi-
cant. Conclusions & Inferences The BEDQ represents
a rapid, reliable, and valid assessment tool for
esophageal dysphagia with food impaction for clinical
practice that differentiates between patients with
major motor dysfunction and mechanical obstruction.
Keywords esophageal dysphagia, food impaction,
questionnaire validation.
INTRODUCTION
Esophageal dysphagia is a common symptom in
gastroenterology practices and is loosely defined as
‘difficulty with swallowing’. Mechanistically, this type
of dysphagia is separated into structural, associated
with an overt obstruction, and non-structural,
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associated with no evidence of an anatomical cause on
endoscopy.1,2 A subset of patients with esophageal
dysphagia experience acute food impaction, which has
an annual incidence of approximately 13 cases per
100 000 people per year and is the third most common
non-billiary endoscopic emergency after upper and
lower gastrointestinal hemorrhage.3 The main causes
of food impaction are structural diseases such as
esophageal stricture, Schatzki ring, and eosinophilic
esophagitis.3–8 However, food impaction also occurs in
conditions characterized by abnormal motor function
(e.g. achalasia) and distinguishing these entities by
history alone may be difficult.
Non-structural esophageal dysphagia can present
with symptoms related to poor bolus transport and
obstruction at the lower esophageal sphincter due to
abnormal motor function.9 Abnormal perception sec-
ondary to visceral hypersensitivity in the context of
normal or borderline motor function also leads to
dysphagia symptoms.10–12 In these cases, esophageal
dysphagia is often accompanied by other symptoms
including regurgitation, heartburn, and chest pain,13
further complicating the assessment of this symptom
simply as ‘trouble swallowing’.
While several measures have been developed to
evaluate oropharyngeal dysphagia14 fewer exist to
evaluate esophageal dysphagia; these include the
Mayo Dysphagia Questionnaire – 30 (MDQ30),15
the Esophageal Symptoms Questionnaire (ESQ),16 the
Dysphagia Symptom Questionnaire (DSQ),17 and the
Eosinophilic Esophagitis Symptom Activity Index
(EEsAI-PRO).18 The MDQ30 is a comprehensive
assessment tool designed to gauge dysphagia fre-
quency and severity in the past 30 days, and the
presence of gastroesophageal reflux disease (GERD) or
allergic symptoms, medication use, and prior surgical
history for dysphagia; the ESQ is a similar measure
that gauges frequency and intensity of esophageal
symptoms including dysphagia, reflux, and globus.
The DSQ and EEsAI are disease-specific measure for
Eosinophilic Esophagitis that could be tailored to
other conditions. Due to their length, the EEsAI,
MDQ30, and ESQ may be challenging to implement
in day-to-day clinical practice. The DSQ is short,
being only 3 items, but requires repeated measure-
ment via an electronic diary and thus, is not con-
ducive to an outpatient clinic setting. An additional
scale, the Straumann Dysphagia Instrument (SDI), is a
brief questionnaire to measure dysphagia severity;
however, as of the preparation of this manuscript the
SDI is not validated.17,19 These limitations to current
measures present an important limitation in the
management of esophageal dysphagia, as simple
reliable measures of symptom severity in the outpa-
tient setting could be utilized to follow patients
before and after interventions to inform future treat-
ment options.
We aimed to develop a rapid assessment tool (less
than 5 min) to identify the presence and severity of
esophageal dysphagia symptoms, including experi-
ences with food impaction, to aid clinicians in gather-
ing information during outpatient visits. Our
secondary goal was to create a general symptom score
that could be utilized in both structural and non-
structural disease processes to simplify the reporting
process for both the patient and healthcare provider.
We hypothesized that this measure could be utilized to
help make decisions regarding the requirement for
further diagnostic testing and whether endoscopic or
surgical interventions are needed.
MATERIALS AND METHODS
This study was conducted in two phases: phase 1 data evaluated
the internal consistency and reliability (measured via Cronbach
alpha and the Guttman statistic for split-half reliability) and the
factor structure (measured via Principle Components Factor
Analysis) of the BEDQ, phase 2 data evaluated the concurrent,
construct, and predictive validity of the measure. For both study
phases, potential participants ages 18 and older with a docu-
mented ICD-9 diagnosis of GERD or dysphagia NOS (Not
Otherwise Specified) for at least 6 months were approached
consecutively during their routine visit to a university-based
outpatient gastroenterology clinic. Participants in phase 2 also
had one high resolution esophageal manometry performed at the
study center prior to study enrollment documented in the
electronic medical record (EMR). Informed consent was obtained
and clinical data outlined below were prospectively collected via
the EMR at the time of participant consent. Participants also
completed study questionnaires.
Phases 1 and 2
Demographic information: gender, age, race, ethnicity Clinical
data: gastrointestinal diagnosis—Brief Esophageal Dysphagia
Questionnaire (Tested version; BEDQ) – Preliminary Version:
The initial version of the BEDQ is a 10-item self-report measure of
dysphagia symptom frequency (5 items), severity (3 items), and
impaction (2 items). Symptom frequency (e.g. ‘trouble eating solid
food (meat, bread)’, ‘coughing or choking while swallowing foods
or liquids’) is measured on a 6-point Likert scale from ‘never’ to
‘daily’ during the past 30 days. Symptom severity (e.g. ‘Eating
solid food [meat, bread, vegetables]’, ‘drinking liquids’) is mea-
sured on a 6-point Likert scale from ‘none’ to ‘severe’ during the
past 180 days. Impactions (e.g. ‘an emergency room visit because
of food being stuck in throat or esophagus’) are measured on a 6-
point Likert scale from ‘never’ to ‘more than four times’ during
the past 12 months. Items on the BEDQ were selected by
consensus from two gastroenterologists with expertise in treating
dysphagia and other esophageal conditions and are scored from 0
to 5. Higher scores indicate greater impaction dysphagia. The
BEDQ takes 1–2 min to complete. The final version of the BEDQ,
taking into account modifications based on study findings, is
found in Appendix S1.
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Phase 2
Additional clinical data Esophageal manometry results (esopha-
gogastric junction outflow obstruction, esophageal spasm, absent
contractility, hypercontractility) categorized patients as having
major motor dysfunction (yes/no). Endoscopy and/or esophagram
results (stricture, eosinophilic esophagitis, mass, postsurgical
conditions, cricopharyngeal bar) categorized patients as having a
mechanical obstruction (yes/no), and large (>5 cm) hiatal hernia
(yes/no). Distal contractile integral (DCI) and integrated relax-
ation pressure (IRP) values provided gold standard assessment
points of esophageal dysfunction severity. Body mass index (BMI)
was also recorded.
Visceral sensitivity index The visceral sensitivity index (VSI) is a
15 item self-report measure of a patient’s gastrointestinal symp-
tom-specific anxiety within five domains: worry, fear, vigilance,
sensitivity, and avoidance.20 Items are rated on a 6-point Likert
scale (strongly agree to strongly disagree) and yield an overall
score. The VSI is widely used in gastrointestinal research, and
demonstrates excellent reliability (Cronbach a = 0.93) and valid-
ity. Higher scores indicate greater visceral anxiety.
Hospital Anxiety & Depression Scale The Hospital Anxiety &
Depression Scale (HADS) is 14-item measure of psychological
distress.21 Items are rated on a 3-point Likert scale and responses
summed to yield 2 scores (anxiety and depression). The HADS is a
common measure of psychological functioning in medical popu-
lations and demonstrates good reliability (Cronbach a from 0.65 to
0.90, mean = 0.82). A cutoff score of 8 is recommended for
positive symptoms of each condition.
Gastroesophageal Reflux Disease Questionnaire The GERD
Questionnaire (GERDQ) is a 6-item questionnaire that measures
frequency of GERD symptoms, problems sleeping, and increased
medication use during the previous week.22,23 Items are rated on a
4-point Likert scale (0 days to 4–7 days). Scores range from 0 to 18
with higher scores indicating more symptoms.
Following statistical analyses, the study team reviewed the
BEDQ for potential item reduction and/or revision based on
reliability statistics, ceiling and floor effects, and inter-item
correlations. This study was reviewed and approved by the
Institutional Review Board of Northwestern University.
Statistical analyses
Data were entered into SPSS version 23 (IBM-SPSS, Inc., Chicago
IL, USA) for analysis. Descriptive statistics (percentages, mean +
SD) evaluated the demographic and clinical variables of the
sample by phase. Internal consistency and reliability of the BEDQ
were evaluated using Cronbach’s a, inter-item correlation, and
Guttman split-half reliability statistics. Tests for normal distri-
bution (skewness, kertosis between 2.0 and +2.0) and mean + SD
were conducted to identify potential ceiling (upper limit to values
the scale can reliably specify) and floor (lower limit to values the
scale can reliably specify) effects for each item of the BEDQ.24
Principle components factor analysis (PCFA) with varimax rota-
tion evaluated the dimensionality of the BEDQ. Concurrent
validity of the BEDQ was verified via Pearson’s correlations with
the VSI and HADS which measure variables consistently shown
to be related to gastrointestinal symptoms (e.g. psychological
distress) and the GERDQ. Construct validity was assessed via
additional Pearson’s correlations between the BEDQ, IRP, and
DCI. Independent samples t-tests evaluated the construct validity
of the BEDQ by measuring significant differences between
patients with and without major motility disorders, mechanical
obstructions, or presence of a large hiatal hernia.
The predictive ability of the BEDQ for major motor disorder,
mechanical obstruction, or large hernia was evaluated two ways.
First, three separate binary logistic regression analyses evaluated
the predictive ability of the BEDQ for each diagnostic group.
Variables were entered in a forward, conditional process. Nagelk-
erke R Square, Omnibus tests, and Hosmer and Lemeshow test
evaluated the accuracy of the logistic regression model. Odds ratio
with 95% confidence interval (CI) are reported. Second, three
separate receiver operator characteristics (ROC) curve analyses
established proposed cut-off scores for the BEDQ to identify each
diagnostic group. A minimum acceptable area under the curve
(AUC) was set for 0.70. Cut points with sensitivity (true positive)
and specificity (false positive) values are reported with the optimal
cut point based on the Youden index, or the point on the ROC
curve where sensitivity and specificity are maximized.25
RESULTS
A total of 1613 participants completed the study; 744
participants completed phase 1 and 869 phase 2. Study
recruitment occurred between 2009 and 2012. Demo-
graphic and clinical characteristics of the sample are
listed in Table 1. The sample was evenly divided
between genders and heavily sampled from Caucasian
and Non-Hispanic sources. On average, participants
were middle-aged (range: 18–92 years) and overweight
(BMI ≥25, range: 15–44). Approximately 30% had major
motor dysfunction, 20% mechanical obstruction, and
10% large hiatal hernia. No participants met the
criteria for more than one category (e.g. mechanical
obstruction and large hernia).
Internal consistency, reliability, and factor
structure of the BEDQ
Overall, the BEDQ demonstrated excellent reliability
(a > 0.70) two of the three subscales (Table 2). The
Table 1 Demographic and clinical characteristics of study sample
Variable
% (N) or mean  SD
Part 1 (n = 744) Part 2 (n = 869)
Gender
Male 43.0% (320) 39.6% (344)
Female 51.4% (383) 59.8% (520)
Race
Caucasian 87.9% (655) 90.0% (782)
African/American 8.1% (60) 7.0% (61)
Other 3.9% (30) 3.0% (26)
Ethnicity
Hispanic 5.4% (40) 6.1% (53)
Non-Hispanic 92.8% (691) 93.9% (816)
Age 48.73  14.9 52.76  16.1
Body mass index – 27.49  6.0
Major motor dysfunction – 28.9% (251)
Mechanical obstruction – 18.3% (159)
Large hiatal hernia – 10.1% (88)
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‘impaction’ scale demonstrated poor consistency
(a = 0.18). However, internal consistency was excel-
lent for the total scale, with the impaction items
included and removed (both >0.90). Correlations
between BEDQ questions were within the acceptable
cut-off range (0.30–0.80) for all items. No significant
ceiling or floor effects were noted for the individual
scale items with the exception of the question mea-
suring emergency room visits due to food impaction
(92% responded ‘never’; floor effect).
Based on the poor consistency of the ‘impaction’
items, two separate PCFA evaluated the scale’s dimen-
sions. The first PCFA included all scale items and
resulted in a single scale (Eigenvalue = 5.53, 55% of
the variance explained). Item correlations ranged from
0.24 (ER visits in past year) to 0.84 (Trouble swallowing
liquids). The second PCFA removed the two impaction
items, also resulting in a single scale (Eigen-
value = 5.17, 65% of the variance explained). Item
correlations ranged from 0.69 (Coughing or choking
while swallowing foods) to 0.85 (Trouble swallowing
liquids).
Concurrent, construct, and predictive validity of
the BEDQ
The BEDQ demonstrated adequate concurrent validity
as exhibited by significant correlations with outcomes
measures included in the study (Table 3). The BEDQ
was moderately correlated with related constructs
measured by the HADS, VSI, and GERDQ, with the
largest correlation with depression (r = 0.29, p < 0.05).
The relationship with BMI was non-significant, how-
ever, BMI did show a small correlation with the
GERDQ (r = 0.18, p < 0.05).
Construct validity is supported by patients with
major motor dysfunction reporting significantly higher
BEDQ scores than those without, t(867) = 11.02,
p < 0.001 (mean (SD): yes = 18.1 (12.1), no = 9.2
(10.2)), those with mechanical obstruction scoring
higher than those without, t(458) = 3.46, p = 0.001
(yes = 12.6 (10.8), no = 8.3 (10.1)), and those with a
large hiatal hernia scoring higher than those without, t
(453) = 2.02, p = 0.04 (yes = 9.5 (10.4), no = 7.1 (9.5)).
Significant correlations exist between the BEDQ and
adequacy of esophagogastric junction (EGJ) relaxation
with swallowing (i.e. IRP value; r = 0.33, p < 0.01) and
strength of distal esophageal contraction (i.e. DCI
value; r = 0.11, p < 0.05), further supporting the
BEDQ’s validity.
The predictive ability of the BEDQ for two of the
three diagnostic categories was small but significant
(Table 4). Patients with higher scores on the BEDQ
are 1.1 times more likely to have major motor
dysfunction and 1.04 times more likely to have
mechanical obstruction when controlling for GERDQ,
VSI, and HADS scores. No significant predictive
relationship existed between the BEDQ and large
hiatal hernia. Receiver operator characteristics curve
analyses yielded a significant and acceptable AUC for
major motor dysfunction (AUC = 0.73; Fig. 1) but not
for mechanical obstruction (AUC = 0.64) nor large
hiatal hernia (AUC = 0.35). Table 5 outlines proposed
cut scores for the BEDQ and diagnosing major motor
dysfunction. The best cut point that maximizes
(sensitivity + specificity) is a score of 10 on the
BEDQ.





Symptom frequency (items 1–5) 0.872 0.808
Symptom severity (items 8–10) 0.861 0.755
Impaction (items 6 and 7) 0.180 0.180
Total scale with items 6 and 7 0.901 0.865
Total scale less items 6 and 7 0.917 0.898
Table 3 Pearson’s correlations of BEDQ with heartburn symptoms,
visceral sensitivity, psychological variables, and BMI
Measure r p
Visceral Sensitivity Index 0.27 <0.001
HADS – anxiety 0.22 <0.001
HADS – depression 0.29 <0.001
Gastroesophageal Reflux Disease Questionnaire 0.21 <0.001
Body mass index 0.09 0.18
Table 4 Logistic regression analyses of BEDQ for major motor
dysfunction and mechanical obstruction
OR 95% CI p
Major motor disorder
BEDQ 1.06 1.04–1.09 <0.001
VSI 0.09
GERDQ 0.98
HADS – anxiety 0.30
HADS – depression 0.88
Mechanical obstruction
BEDQ 1.04 1.01–1.07 0.02
VSI 0.55
GERDQ 0.81
HADS – anxiety 0.80
HADS – depression 0.24
VSI, GERDQ, and HADS were removed from each regression model
due to non-significance.
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Final questionnaire design
The final version of the BEDQ retains the original 10
items evaluating frequency and severity of dysphagia
symptoms. Based on 2009 FDA guidelines for scale
development, the timeframe for each scale was mod-
ified from its original 30 or 180 days to 14 days for
frequency and severity, while 1 year was retained for
the impaction questions due to the likely infrequent
nature of these events in a 14 day period. An additional
change for the frequency and severity scales includes
qualifier responses to determine if respondents are able
to eat each food type should a patient avoid a particular
food category (e.g. solids) altogether. If a respondent is
unable to eat a type of food, they are instructed to
check the ‘Cannot Eat’ column, which automatically
receive the maximum score (5 out of 5). Total scores
range from 0 to 40. Further validation of the BEDQ in
its modified form is warranted to ensure its strong
reliability and validity is retained.
DISCUSSION
We found the BEDQ to be a reliable and valid
unidimensional measure of dysphagia severity in a
large cohort of GERD and dysphagia patients visiting
an outpatient gastroenterology practice. The measure
allows for rapid assessment (under 2 min) of self-
reported symptom severity and frequency. Measures of
internal consistency, split-half reliability, and con-
struct validity were at or above established guidelines
for scale development.
The BEDQ was modestly correlated with gastroe-
sophageal reflux symptoms, visceral hypersensitivity,
and psychological distress, all of which support con-
struct validity.26–29 The BEDQ also identified differ-
ences in scores between patients with a major motor
disorder, mechanical obstruction, or the presence of a
large hernia. While the odds ratios are small, the BEDQ
may significantly predict major motor dysfunction and
mechanical obstruction in patients. Clinical utility of
this predictive ability should be considered with
caution as the corresponding effect size for an odds
ratio less than 1.5 is likely very small. However, ROC
curve analyses only maintain a reasonable, fair predic-
tive ability of the BEDQ for major motor dysfunction
with a suggested score of 10 to identify patients with a
positive diagnosis. Additional studies are warranted to
understand the diagnostic accuracy and reliability of
the BEDQ to distinguish patients with major motor
dysfunction from those who do not.
Internal consistency for the BEDQ was excellent,
even with the inclusion of 2 scale items that demon-
strated poor consistency and floor effects. Because the
‘impaction’ scale exhibited poor internal consistency
but did not reduce the overall reliability of the BEDQ,
the two items were converted to open-ended response
to record the number of times each scenario had
occurred in the past year (replacing the original Likert
scale) and removed from the total score summation.
Based on consensus from two gastroenterologists (JP,
PK), guidelines to interpret responses to the impaction
items were developed as follows: in all patients, if at
least 1 ER visit for food impaction is present, more
thorough evaluation is warranted. For patients who
have yet to receive an esophageal diagnosis, one or
more self-limited food impactions warrants endoscopic
evaluation. Finally, in patients who have a known
esophageal disorder such as EoE or achalasia, or an
esophageal stricture, greater than two self-limited food
impactions over 12 months would necessitate further
Figure 1 ROC curve for presence of a major motor disorder.
AUC = 0.73, 95% confidence interval = 0.69–0.76, p < 0.001.
Table 5 Cut points for BEDQ as predictor of major motor disorder









*First score to yield 0.90 or greater sensitivity.
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evaluation and consideration of intervention. These
two ‘impaction’ questions function to gauge esopha-
geal dysphagia severity over the past year and bring
additional clinical utility to the BEDQ to guide diag-
nostic intervention. See Appendix S1 for the final
version of the BEDQ.
While existing assessment tools, such as the
MDQ30, provide in-depth information about esopha-
geal dysphagia symptoms that is critical for clinical
research, their implementation in day-to-day clinical
practice can be challenging. Like the GERDQ,22 the
BEDQ allows for evaluation in the clinical setting in
under 5 min. The short length of the BEDQ also
reduces the likelihood of issues common to assessment
scales such as fatigue, straight-line answering, or
incomplete data.30,31 However, some research suggests
that shorter questionnaires are not necessarily superior
to longer assessment tools.32
There are some limitations to the present study that
should be taken into consideration. The study sample
was primarily Caucasian and non-Hispanic. While data
regarding racial and ethnic differences for esophageal
dysphagia are limited, some studies suggest racial
differences exist in dysphagia prevalence33,34 and
symptom presentation.35 Therefore, caution should
be applied when using the BEDQ among racial and
ethnic minorities until it is evaluated in more diverse
populations. The diagnosis of GERD may not typically
present with dysphagia symptoms, and the dysphagia
NOS group is poorly defined in terms of underlying
esophageal diagnosis (e.g. achalasia, eosinophilic
esophagitis) so the relationship between the BEDQ
and the underlying esophageal disorder is uncertain.
Only cross-sectional data for the BEDQ were collected
so the temporal stability of BEDQ scores is not known.
Additional validation of the BEDQ is warranted. This
includes evaluating the accuracy of suggested diagnos-
tic cut-off scores and impaction guidelines with mano-
metric and other pathophysiological data, comparison
of the BEDQ to the MDQ30, and test–retest evaluation.
In summary, we have developed a rapid tool to assess
frequency and severity of dysphagia symptoms and
food impactions in the outpatient setting. This tool
could be utilized to follow patients before and after
intervention and help determine which patients will
require further evaluation and treatment; prospective
trials are needed to confirm this use. We are optimistic
that this tool could be utilized in large population
based studies as it can easily be recorded in the EMR
while other, more comprehensive measures such as the
MDQ are utilized in settings requiring more detailed
assessment. Future studies will determine whether
improvement or normalization of BEDQ score is
associated with good treatment outcomes in both
structural and non-structural esophageal dysphagia.
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